The immunodominance of RBD antigen of delta variant as vaccine candidate against SARS‐CoV‐2 infection

alexandrossfakianakis shared this article with you from Inoreader The immunodominance of RBD antigen of delta variant as vaccine candidate against SARS‐CoV‐2 infection via Journal of Medical Virology Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel subset of coronavirus that causes coronavirus disease 2019 (COVID-19), but vaccine development is hampered by the high mutation of virus This article is protected by copyright. All rights reserved. View on Web

Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.